A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.

What is urgently needed is a shift from pathogen-specific diagnostics toward pathogen-agnostic diagnostic systems,” write ...

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen ...

CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.

The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...

Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

The hospital operator Nutex enriched itself by exploiting loopholes in laws meant to protect patients, STAT found.

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...